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ABSTRACT
Molecular evolution is a powerful means of engi-
neering proteins. It usually requires the generation
of a large recombinant DNA library of variants for
cloning into a phage or plasmid vector, and the
transformation of a host organism for expression
and screening of the variant proteins. However,
library size is often limited by the low yields of
circular DNA and the poor transformation efficien-
cies of linear DNA. Here we have overcome this
limitation by amplification of recombinant circular
DNA molecules directly from ligation reactions. The
amplification by bacteriophage Phi29 polymerase
increased the number of transformants; thus from
a nanogram-scale ligation of DNA fragments com-
prising two sub-libraries of variant antibody
domains, we succeeded in amplifying a highly
diverse and large combinatorial phage antibody
library (.10
9 transformants in Escherichia coli and
10
5-fold more transformants than without amplifi-
cation). From the amplified library, but not from the
smaller un-amplified library, we could isolate sev-
eral antibody fragments against a target antigen. It
appears that amplification of ligations with Phi29
polymerase can help recover clones and molecular
diversity otherwise lost in the transformation step. A
further feature of the method is the option of using
PCR-amplified vectors for ligations.
INTRODUCTION
The assembly of self-replicating, circular DNA molecules and
their transformation into bacteria as ﬁrst reported by Berg and
co-workers in 1972 (1) lies at heart of recombinant DNA tech-
nology. However the assembly (by ligation) of circular DNA
molecules from cohesive linear fragments is inefﬁcient espe-
cially with multiple fragments (2), as is the transformation of
bacteria (3). Less than 1 in 10
2 molecules of circular super-
coiled plasmid can be successfully transformed (4), and for
linear molecules the efﬁciency is even lower (<1i n1 0
5 mole-
cules) (5). To obtain large numbers of recombinant clones, it is
thereforeusuallynecessarytouselargeamountsofDNAforthe
ligations, and to undertake multiple transformations. Here we
have investigated an alternative strategy; to amplify circular
DNA by the use of bacteriophage Phi29 polymerase. As the
enzyme speciﬁcally ampliﬁes DNA circles (6–8) at the
expense of short linear DNA molecules, we realized that it
might be suited for the ampliﬁcation of circular (and trans-
formable DNA) directly from ligation reactions.
Phi29polymerasehastheuniquepropertyofcatalyzingstrand
displacement synthesis with high processivity (9) and low error
rate (10), and unlike PCR introduces little bias into the ampliﬁed
population,asshownforwhole-genomeampliﬁcations(11).Sev-
eral applications of Phi29 polymerase for the ampliﬁcation of
DNA molecules have been reported (6,12–17). These include
the ampliﬁcation of DNA circles such as plasmid and phage
genomes (6), as well as extended linear molecules such as
human chromosomes (17). Most approaches are based on the
work of Laskenand co-workers (6), andrely onrandom priming
using high concentrations of short synthetic oligonucleotides.
The ampliﬁcation is based on a rolling-circle mechanism and
leads to linear concatamers containing multiple template repeats
(6). This process is facilitated by the strongly strand displacing
properties of the polymerase and high primer concentrations.
Thetandemrepeatsaresubsequentlyusedastemplatesforfurther
ampliﬁcation, thereby producing extensive amounts of linear
DNA suitable for sequencing and hybridization.
MATERIALS AND METHODS
Model amplifications
Regions of the pUC19 plasmid (18) were ampliﬁed by PCR
using primers 50-GAAATTGCGGCCGCATTTTTAATTTA-
AAAGGATCTAGGTG-30 and 50-TGCATTCTCGAGCATT-
TCCCCGAAAAGTGCCACCTG-30. A fragment encoding
the b-lactamase (bla) gene (ampicillin resistance marker)
was ampliﬁed from pUC 19 using primers 50-ACTATTGCG-
GCCGCGAAGTTTTAAATCAATCTAAAG-30 and 50-CC-
AAGTCTCGAGTTACTTACTTATGTGCGCGGAACCCC-
TATTTG-30, while the chloramphenicol-acetyl-transferase
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doi:10.1093/nar/gkl605(cat) gene (chloramphenicol resistance marker) was ampliﬁed
from plasmid pBCSK
+(Invitrogen) using primers 50-
AGGTCACTCGAGTAAAGTAAGGCACGTAAGAGGTT-
CCAAC-30 and 50-GTAGCAGCGGCCGCCGAATTTCTG-
CCATTCATC-30. All PCR ampliﬁcations were performed
using Expand HighFidelity polymerase (Roche). The
ampliﬁed fragments were digested with XhoI and NotI
(New England Biolabs) (Phosphatase treatment of DNA
should be avoided, as the presence of gaps in the circular
product will prevent rolling-circle ampliﬁcation) and puri-
ﬁ e db yg e le l e c t r o p h o r e s i s .D N Aconcentrations were deter-
mined by measuring absorbance at 260 nm. After
puriﬁcation, ligations were performed over night at 16 C
at a concentration of 40 ng/ml vector and 40 ng/mli n s e r t
u s i n g1 6U / ml of T4 DNA ligase in ligase buffer (New Eng-
land Biolabs). Ligation reactions were puriﬁed by phenol/
chloroform extraction and diaﬁltration. Dilutions were per-
formed by serial dilution of bla ligations into cat ligations
(5-fold dilution steps were used).
Phi29 ampliﬁcations were performed in a 50 ml volume
using 10 ng of puriﬁed ligation reaction as a template and
10 U of Phi29 polymerase (New England Biolabs). Reaction
conditions were as follows: 1 mM dNTPs, 50 mM random
hexamer primer, 0.1 mg/ml BSA, 50 mM Tris–HCl pH 7.4,
10 mM (NH4)2SO4, 10 mM MgCl2, 4 mM DTT. The reaction
was incubated over night at 30 C and puriﬁed by phenol/
chloroform extraction and diaﬁltration. The ampliﬁed con-
catemer was digested over night with NotI and the restriction
digest puriﬁed using a PCR puriﬁcation kit (Qiagen).
Plasmids were re-circularized by self-ligation at dilute DNA
concentrations (<1 ng/ml) using 4 U/ml of T4 DNA ligase in
ligase buffer. After 2 h at room temperature the ligase was
inactivated by phenol/chloroform extraction and the reaction
concentrated by diaﬁltration. The reaction was transformed
into E.coli TG1 (19) by electroporation and plated on agar
plates containing 4% glucose and either 100 mg/ml ampicillin
or 15 mg/ml chloramphenicol. Plates were incubated at 37 C
over night.
Library construction
As a template we used a previously reported synthetic domain
antibody repertoire, ‘library 1’ (20), based on the human
DP47 heavy chain framework. The library incorporates
diversity in all three CDR regions and is cloned in a phage
format. The repertoire was pre-selected to enrich for antibod-
ies that resisted aggregation upon heating (data not shown).
Regions of the library comprising to CDRs1/2 and CDR
3 (all with attached framework regions) were ampliﬁed by
PCR from a plasmid preparation. Primer pairs 50-ACGTC-
AGAAGACATCAGGTGCAGCTGTTGGAGTC-30,5 0-TG-
GACTGAAGACAGTCACGGAGTCTGCGTAGTATGTG-
30 (CDR1/2) and 50-GTAACTGAAGACTAGTGAAGGG-
CCGGTTCACCATC-30,5 0-TCAGTTGAAGACCTCGAAT-
TCAGATCCTCTTCTGAGATG-30 (CDR3) were used in




The phagemid is derived from pHEN1 (21) and encodes a
VSV tag upstream of the phage gene III. Ampliﬁcations
were performed using Expand HighFidelity polymerase
(Roche). DNA concentrations were determined by measuring
absorbance at 260 nm. The ampliﬁed fragments were digested
with BbsI (New England Biolabs), gel puriﬁed and ligated
at 16 C for 6 h in a three-way ligation using 40 U/mlo fT 4
DNA ligase in ligase buffer (New England Biolabs). Vector
concentrations of 40 ng/ml and insert concentrations of
22 ng/ml (CDR1/2) and 33 ng/ml (CDR3) were used in the
ligation. After heat inactivation (5 min at 70 C) and diaﬁltra-
tion, 125 ng of the reaction was either used as template
for Phi29 ampliﬁcation or directly transformed into E.coli
XL-1 Blue (Stratagene) by electroporation and plated on
agar plates containing 4% glucose and 100 mg/ml ampicillin
and incubated at 37 C over night.
Phi29 amplification of antibody library
Ampliﬁcations were performed using a 500 ml starting vol-
ume and 125 ng of puriﬁed ligation reaction as a template
(reaction conditions as above). Due to the increased reaction
volume the concentration of Phi29 polymerase was reduced
to 0.025 U/ml in order to minimize the amount of enzyme
required (as was the concentration of ligase, as below). The
reaction was heated at 70 C for 5 min before adding the poly-
merase and incubated at 30 C. The reaction volume was
doubled every 3 h by adding reaction mixture and polymerase
(no additional template was added) up to a volume of 8 ml.
After an additional 3 h at 30 C the reaction was stopped by
heating to 70 C for 20 min.
The ampliﬁed concatemer was cleaved by digestion with
HindIII (New England Biolabs), the restriction endonuclease
was heat inactivated and the reaction concentrated by diaﬁl-
tration. Excess random hexamer primers were removed by gel
ﬁltration on a Sephacryl S300 column (Amersham). Plasmids
were re-circularized by self-ligation at dilute DNA concentra-
tions (<3 ng/ml) using 0.7 U/ml of T4 DNA ligase in ligase
buffer (New England Biolabs). After incubation for 2 h at
room temperature the ligase was heat inactivated (20 min at
70 C) and the reaction concentrated by dialﬁltration. The
reaction was transformed into E.coli XL-1 Blue (Stratagene)
by electroporation of 1 ml in 20 separate transformations,
plated on agar plates containing 4% glucose and 100 mg/ml
ampicillin and incubated at 37 C over night.
For analyses of transformation efﬁciencies, 125 ng portions
were transformed in ﬁve separate reactions into E.coli XL-1
Blue bacteria by electroporation, plated on agar plates con-
taining 4% glucose and 100 mg/ml ampicillin and incubated
at 37 C over night (a single batch of competent cells was
used).
Selection of binders
Libraries were re-transformed into E.coli TG1 (19) for selec-
tion. Phages were produced by co-infection with helper phage
KM13 (22). Binding selections were performed directly from
culture supernatant using strepavidin–Sepharose (Amersham)
and biotinylated b-galactosidase (Sigma-Aldrich). Marvel
milk powder and Tween-20 were present during the binding
steps [5% (w/w) and 2% (v/v), respectively]. Washes
were performed with phosphate buffered saline supplemented
with 0.05% (v/v) Tween-20. Phages were eluted with
10 mg/ml trypsin and used to infect TG1 bacteria. For the
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was directly immobilized on MaxiSorb plates (Nunc).
Analysis of selected antibodies
Binders were detected after two rounds of selection by
ELSA using b-galactosidase coated MaxiSorb plates (as
above), anti-M13 HRP-conjugate (Amersham) and 3,30,5,
50-tetramethylbenzidine as substrate. For expression, phage-
mids were transferred into E.coli HB2151 by phage infection.
Proteins were puriﬁed using a Streamline rProteinA column
(Amersham), followed by acid elution and gel ﬁltration on
a Sephadex HR75 column (Amersham). Surface plasmon
resonance measurements were performed on a Biacore
2000 instrument using biotinylated b-galactosidase (Sigma-
Aldrich), streptavidin (SA) chips and HBS-EP running buffer
(Biacore).
RESULTS
Amplification of ligation reactions
In a ﬁrst step we tested whether our approach would amplify
circular DNA from ligation reactions. As a model system
we ligated an antibiotic resistance marker into a bacterial
plasmid; we used PCR-ampliﬁed fragments comprising the
origin of replication of the Escherichia coli plasmid pUC19
and the ampicillin resistance marker from the same plasmid.
After restriction digestion the resulting PCR products were
joined by ligation.
A dilution series was prepared from the ligation reaction
and used as a template for Phi29 ampliﬁcation. Hexamer
primers and Phi29 polymerase were added and the reactions
incubated isothermally at 30 C over night, allowing circular
ligation products to be ampliﬁed through a rolling-circle
mechanism (Figure 1). After ampliﬁcation the resulting linear
concatemers were cut with restriction endonuclease, and the
plasmids were re-circularised by self-ligation at low DNA
concentrations. Both ampliﬁed and un-ampliﬁed reactions
were electroporated into E.coli bacteria and plated on agar
plates containing ampicillin.
Phi29 ampliﬁcation signiﬁcantly increased the number
of transformants ( 50-fold), with the number of colonies
directly proportional to the amount of template DNA used
(Figure 2). We were able to obtain colonies from the ampli-
ﬁed ligations with template dilutions that yielded no colonies
from the un-ampliﬁed ligations (Figure 2; 5




We then analyzed whether our method was also capable of
amplifying mixtures of DNA molecules without detectable
Figure 1. In vitro amplification of ligation reactions. Linear fragments were joined into recombinant, circular units by treatment with DNA ligase. Hexamer
primers were annealed and Phi29 polymerase added. This causes extensive amplification of circular species through rolling-circle replication and the formation
of extended linear concatemers. The concatemers were cleaved by restriction digestion and re-circularized using DNA ligase.
ligation dilution















Figure 2. Amplification of dilutions of a model ligation reaction.
Products from ligation reactions of ampicillin resistance gene into vector,
were diluted, amplified, and used to transform E.coli, plating in the presence
of ampicillin. The number of colonies (before and after amplification, gray
and black, respectively) was plotted as a function of the dilution of the
ligation reaction.
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had been ‘spiked’ with a constant amount of a ligation reac-
tion incorporating a different, selectable resistance marker (a
PCR-ampliﬁed chloramphenicol gene ligated into the pUC19
vector backbone). From the ratio of the colonies before and
after ampliﬁcation (by counting colonies on ampicillin or
chloramphenicol plates), it appears that these two constructs
are ampliﬁed to a similar extent (Figure 3), despite the differ-
ences in sequences and lengths of the DNAs encoding the two
resistance markers.
Generation of a large antibody repertoire from
nanogram-scale ligation reactions
We generated a repertoire of antibody variable heavy
chains by recombining gene segments from a library (20)
with diversity in all three complementary determining regions
(CDRs) (Figure 4). Thus, we PCR-ampliﬁed a segment com-
prising CDRs 1 and 2, and also a segment comprising CDR
3 from the library. The two segments of ampliﬁed DNAs
were cut with restriction endonuclease and recombined by
ligation into a phagemid vector, itself generated by PCR, in
order to create a combinatorial library. As three-way ligations
are inefﬁcient (2), we tried to optimize the process. For this
purpose restriction sites cleavable by the type IIs restriction
endonuclease BbsI were introduced into the PCR primers,
enabling ‘sticky’ but non-palindromic overhangs and non-
ambiguous assembly. Nevertheless when a portion of the
ligation reaction (comprising 125 ng vector backbone, >10
11
DNA molecules) was directly transformed into E.coli bacte-
ria, only 2 · 10
4 colonies were obtained (and 10
4 fold less
than with the same amounts of circular supercoiled plasmid).
An identical portion of the ligation was then used as a
template for Phi29 ampliﬁcation. This polymerase exhibits
a strong exonuclease activity and primers incorporating phos-
phothioate linkages (that are resistant to such exonucleolytic
attack) have been reported to substantially increase DNA
yields (6). However, we had noted that the incorporation of
phosphothioates also reduced transformation efﬁciencies
(data not shown). We therefore adopted a different strategy;
we added primer at regular intervals during the ampliﬁcation
in an attempt to maintain the primer concentration (see
Material and Methods for details). In addition, the ﬁnal reac-
tion volume was signiﬁcantly increased (160-fold) compared
to the model ampliﬁcations (as above). The ampliﬁed
concatemers were then puriﬁed by gel ﬁltration chromatogra-
phy, cleaved by restriction digestion and the plasmids re-
circularized by self-ligation. The process yielded  0.1 mg
of ampliﬁed DNA (corresponding to a 10
3-fold ampliﬁcation
of the template).
We compared transformation efﬁciencies of the ampliﬁed
and un-ampliﬁed DNA by transforming multiple portions of
each into E.coli bacteria. This revealed that the transforma-
tion efﬁciency of the ampliﬁed DNA was signiﬁcantly higher
than that of the un-ampliﬁed DNA. For example, in a typical
Figure 4. Antibody repertoire by combinatorial ligation. Regions corresponding to CDRs 1/2 and CDR 3 were PCR-amplified and recombined by ligation into a
PCR-amplified phagemid vector backbone. The ligation reactions were either directly electroporated or amplified using Phi29 polymerase followed by
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Figure 3. Amplification of mixtures of two model ligation reactions. Products
from ligation reactions of ampicillin and choroamphenicol resistance genes
into vector were mixed in different ratios, amplified and used to transform
E.coli in the presence of ampicillin or choramphenicol. The ratio of the
number of colonies (ampicillin/choramphenicol) growing under the two
different antibiotic selections (before and after amplification, gray and black,
respectively) was plotted as a function of the ratios of the original mixtures
(ampicillin/chloramphenicol).
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un-ampliﬁed DNA yielded 3 · 10
6 and 10
4 colonies, respec-
tively. The colony numbers differed by an average factor of
300-fold over ﬁve experiments. Clones from the transformed
repertoires were analyzed by DNA sequencing; of these
31/36 (ampliﬁed) and 36/46 (un-ampliﬁed) were free of
mutations (outside the CDR regions) and encoded full-length
antibody domains. Thus, no detectable increase of point
mutations or rearrangements was observed for the ampliﬁed
repertoire.
After these preliminary experiments we generated a large
repertoire in bacteria by transforming 1 mg portions of the
ampliﬁed DNA into E.coli. Each portion yielded  1.5 ·
10
8 colonies; 20 portions were pooled, providing a library
of 3 · 10
9 transformants. The Phi29 ampliﬁcation had
therefore increased the number of transformants by more
than 10
5-fold, due to both the greater amounts of transformed
DNA ( 160-fold) and its higher transformation efﬁciency
( 900-fold).
Analysis of library and selection of binders
To characterize the libraries we selected binders from both
the ampliﬁed and un-ampliﬁed antibody library (encompass-
ing 3 · 10
9 and 2 · 10
4 transformants, respectively) by phage
display. We used b-galactosidase as the antigen, performed
two rounds of binding selections and then screened 18 clones
of each repertoire by phage ELISA (23). Among these,
seven phage clones from the ampliﬁed repertoire bound to
b-galactosidase as shown by ELISA (but did not bind to
BSA), and were found to comprise four unique antibody
domain sequences (Supplementary Data). No binders were
observed for the un-ampliﬁed repertoire (Table 1). The four
domains were expressed in E.coli by secretion and puriﬁed
by afﬁnity chromatography using protein A-Sepharose. All
bound to biotinylated b-galactosidase as determined by sur-
face plasmon resonance (but not to the streptavidin-coated




 1 for three of the four proteins (clone
1: 5 · 10
 2 s
 1, clone 2: 1 · 10
 2 s
 1, clone 3: 4 · 10
 2 s
 1).
The off-rates for these single antibody domains are therefore
comparable to those reported for single chain Fv fragments
isolated from a large repertoire (>1010 clones) (24).
CONCLUSIONS
Our results demonstrate that Phi29 polymerase can amplify
ligation reactions in vitro without detectable biases, yielding
sub-milligram quantities of DNA and potentially increasing
the number of transformants in excess of 10
6-fold. This
enabled us to rapidly generate a library of antibody heavy
chains from which binders could be readily selected. We
did not observe any binders in the un-ampliﬁed repertoire,
strongly indicating that the ampliﬁcation process had allowed
us to tap molecular diversity otherwise lost in the transfor-
mation process. The methodology should also be suitable
for the generation of large amounts of non-methylated DNA
for the transformation of eukaryotic species. While for many
host organisms re-circularization of the ampliﬁed concatemer
will increase transformation efﬁciencies, other organisms
(such as yeast) may be directly transformable with linear
DNA.
Our method requires only minute quantities of DNA as a
starting template. This allowed us to assemble transformable
constructs in a single step from PCR products, removing the
need for plasmid preparations or stepwise cloning. It may
also facilitate the cloning of rare DNAs from fossil, environ-
mental or forensic samples, that are frequently not accessible
by direct cloning or ampliﬁcation. Although we have so far
exclusively used the method for the ampliﬁcation of ligation
reactions, it should also be suitable for other applications in
which only limited amounts of circular DNA are available,
such as the ampliﬁcation of BAC libraries. We suggest that
ampliﬁcation of circular DNA by Phi29 polymerase in vitro
has the potential to improve a wide range of cloning tech-
niques that are currently limited by the transformation efﬁci-
ency of the host organism.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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